Peter Martin, MD, discusses the complexities of treating relapsed MCL after treatment with a BTK inhibitor. Peter Martin, MD, addressed the question of how to sequence subsequent lines of therapy for ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. In an interview for Healio's Clinical ...
Despite improved outcomes in newly diagnosed pediatric AML, relapsed disease remains a therapeutic challenge. Factors contributing to slow progress in improving outcomes include inherent challenges in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results